Medical Tourism Market (2026 - 2035)

Medical Tourism Market Summary

The global medical tourism market size was valued at USD 34.0 billion in 2025 and is projected to grow from USD 38.6 billion in 2026 to USD 126.2 billion by 2035, at a CAGR of 14.1% from 2026 to 2035. Turkey dominated the market, accounting for a revenue share of 13.5% in 2025. Market growth is supported by the availability of cost-effective medical procedures, shorter treatment waiting times, and access to advanced healthcare technologies and specialized medical expertise.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

In addition, modern medical equipment, innovative treatments, personalized patient care, and hospitality services are enhancing the overall medical travel experience and encouraging patients to seek healthcare services across international destinations. The availability of comparatively affordable treatment abroad allows patients to access procedures while potentially reducing overall healthcare expenditure. Demand is also increasing for medical procedures that may have limited insurance coverage or availability in patients’ home markets, including gender reassignment surgery, reproductive treatments, dental reconstruction, and aesthetic procedures.

The expanding availability of high-quality healthcare services across international destinations further supports the growth of medical tourism. Accredited hospitals and clinics, skilled medical professionals, advanced medical technologies, modern equipment, and innovative treatment options are strengthening the attractiveness of medical travel. In addition, personalized treatment packages, hospitality services, travel assistance, and other end-to-end patient support are improving the overall experience for international patients and contributing to the growing adoption of medical tourism.

To learn more about this report, Download Free Sample Report

Affordable Healthcare Attracting Medical Tourists

The cost advantage of medical tourism destinations is a major driver of market growth, particularly in countries such as Thailand and Malaysia, where patients can access high-quality healthcare services at comparatively lower prices than in developed markets. Lower operating and treatment costs allow international patients to undergo complex and elective procedures without necessarily compromising the quality of care. For example, an angioplasty procedure in the U.S. can cost approximately USD 55,000 to USD 57,000, compared with around USD 2,500 to USD 3,500 in Malaysia. Such substantial price differences encourage patients from the U.S. and Europe to travel to destinations such as Singapore, Malaysia, India, and Thailand, with potential medical cost savings of approximately 55% to 70%.

Limited insurance coverage for elective procedures is another factor encouraging international medical travel. In the U.S., procedures such as cosmetic surgery, certain dental treatments, fertility procedures, and weight-loss surgeries may not be covered by insurance, prompting patients to consider more affordable treatment options overseas. Thailand, for instance, has gained traction as a destination for fertility treatment due to its established medical infrastructure, experienced fertility specialists, and comparatively affordable services. Fertility centers in Bangkok and Phuket offer assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and fertility preservation, further strengthening the country's appeal among international patients seeking specialized treatment.

Availability of Skilled Surgeons and Advanced Healthcare Services

Countries such as Malaysia and Thailand have established themselves as medical tourism destinations due to the availability of experienced surgeons and specialized healthcare services. In Malaysia, medical treatment costs are estimated to be 30% to 40% lower than those in the U.S., the UK, and several European countries, supporting demand among international patients seeking affordable care. Foreign patients increasingly travel to these destinations for procedures such as facial aesthetic treatments, dental implants, breast implants, facelifts, and liposuction. Continued improvements in healthcare infrastructure, along with the availability of high-quality medical services at comparatively affordable prices, are expected to support growth in the global medical tourism market. In addition, rising international travel and tourism activity is contributing to greater patient mobility and expanding the potential pool of medical tourists.

According to a report by The Nation published in August 2024, Thailand is poised to become a world leader in aesthetic surgery due to increasing demand both domestically and internationally, as noted by the president of the Association of Plastic and Cosmetic Surgeons of Thailand. In addition, he said:

"The cosmetic surgery sector, including both surgical and non-surgical treatments, has witnessed remarkable growth. Thailand's competitive service fees have attracted both local and international clients."

Long Waiting Times for Medical Procedures in Developed Countries

Delays in receiving necessary medical treatment can allow existing conditions to worsen and increase the risk of complications. For example, postponing hip replacement surgery may result in further deterioration of the hip joint, reduced mobility, and worsening pain. In some cases, prolonged delays may also limit the suitability of less invasive alternatives, such as hip resurfacing. Similarly, delaying root canal treatment can allow infection and tooth damage to progress, potentially resulting in tooth loss.

Long waiting times for consultations and elective procedures in developed countries can further encourage patients to seek treatment abroad. For instance, patients in the UK and Canada may face waiting periods of at least four weeks between scheduling an appointment and seeing a physician. Canada reports a relatively high proportion of patients (36%) waiting six days or more for a doctor’s appointment. In the UK, waiting lists for non-essential procedures, including knee reconstruction, can extend to 18 months, while comparable waits in Australia and Canada may reach up to two years. Such delays can encourage international patients to consider medical tourism destinations offering shorter treatment timelines and greater access to specialized procedures.

Market Dynamics

The medical tourism market is expanding as international patients increasingly seek affordable, specialized, and high-quality healthcare services across overseas destinations. Investments in hospitals, specialty clinics, medical infrastructure, and patient support services are improving the capacity of countries to serve international patients. Growth is particularly supported by demand for elective surgeries, fertility treatments, dental procedures, cosmetic treatments, and other specialized medical services. In parallel, advancements in telemedicine, artificial intelligence, digital health platforms, and data analytics are improving pre-treatment consultations, treatment coordination, appointment scheduling, and post-treatment follow-up. These developments are making cross-border healthcare more accessible and convenient while strengthening the overall medical tourism ecosystem.

Market Concentration & Characteristics

The medical tourism industry is characterized by a fragmented competitive structure, with numerous local and regional healthcare providers serving international patients. The market is highly regulated, reflecting the importance of healthcare standards, accreditation, patient safety, and cross-border treatment requirements. Innovation is also high as healthcare providers and medical tourism facilitators increasingly adopt digital technologies to improve patient engagement and streamline services. Service expansion is high, while regional expansion remains moderate. In addition, merger and acquisition (M&A) activity is moderate to high as companies seek to broaden their service portfolios, strengthen market access, and enhance their ability to support international patients.

Technological advancement is reshaping the medical tourism industry by improving access to healthcare services before, during, and after international travel. Technologies such as telemedicine, artificial intelligence (AI), and data analytics are being integrated into patient consultations, treatment planning, appointment management, and follow-up care. Digital health platforms also enable international patients to obtain online consultations, schedule appointments, access medical records, and coordinate treatment remotely. For instance, Egypt's government is developing an online health tourism platform to facilitate medical travel bookings, reflecting the increasing use of digital infrastructure to support international healthcare access.

To learn more about this report, Download Free Sample Report

The medical tourism market is expected to continue to expand as rising disposable incomes, growing healthcare needs, and technological advancements drive cross-border demand for medical services. This expansion is likely to create opportunities for further consolidation as healthcare providers, travel companies, and healthcare service platforms seek to strengthen their capabilities and broaden their market presence. For instance, in September 2024, EaseMyTrip.com announced its entry into the medical tourism sector through the acquisition of a 49% equity stake in Pflege Home Healthcare and a 30% stake in Rollins International. The transactions were part of the company's strategy to integrate healthcare and wellness services into its broader travel offerings, highlighting the growing convergence of travel, healthcare, and wellness within the medical tourism ecosystem.

Governments in several countries recognize the economic contribution of medical tourism and are introducing measures such as tax incentives, financial grants, and streamlined visa processes to attract international patients. These initiatives can strengthen the competitiveness of domestic healthcare providers while encouraging hospitals and medical tourism facilitators to align their services and marketing strategies with national healthcare and tourism objectives. India, for instance, has a substantial base of internationally accredited hospitals offering specialized medical services; however, gaps in comprehensive regulatory frameworks may create challenges related to standardization and oversight across the sector.

High healthcare costs in developed countries continue to encourage patients to explore more affordable treatment options overseas. Destinations such as India, Thailand, and Malaysia offer comparatively lower costs for a range of medical and elective procedures, while established healthcare institutions increasingly provide integrated packages for international patients. These packages may include visa assistance, airport transfers, accommodation, interpretation, treatment coordination, and follow-up support, creating a more streamlined medical travel experience. The combination of cost advantages, specialized healthcare infrastructure, and end-to-end patient services is strengthening the appeal of Asia-Pacific medical tourism destinations. In some cases, treatment costs in countries such as Thailand, Malaysia, and India can be up to 90% lower than those in Western countries, further supporting international patient flows.

Analyst Perspective

The medical tourism market is expanding as patients seek specialized treatments, shorter waiting times, advanced technologies, and comparatively affordable procedures abroad. Improved hospital infrastructure, accreditation, and cross-border healthcare coordination are strengthening established destinations, while government initiatives are promoting medical tourism as an economic growth driver. Demand for cosmetic surgery, dental, orthopedic, fertility, and cardiovascular treatments is also supporting market growth. Hospitals and destinations are investing in international patient centers, digital consultations, multilingual support, and coordinated travel services to enhance patient experiences. Future growth will depend on affordability, clinical quality, physician expertise, accreditation, patient trust, and integrated medical and hospitality services.

Treatment Type Insights

The cosmetic segment held the largest revenue share of 24.2% in 2025, supported by increasing awareness of aesthetic procedures, rising demand for anti-aging treatments, and the comparatively high cost of cosmetic procedures in developed countries. Growing emphasis on personal appearance and wellness is encouraging more patients to seek affordable treatment options abroad, particularly for procedures such as liposuction, abdominoplasty, breast augmentation, and gluteal augmentation. The expanding availability of specialized cosmetic clinics and internationally oriented healthcare providers is further strengthening cross-border demand. According to the International Society of Aesthetic Plastic Surgery, approximately 33.7 million surgical and non-surgical aesthetic procedures were performed worldwide in 2023, up from around 30.3 million in 2021, underscoring the continued expansion of global aesthetic care.

The infertility segment is anticipated to grow at the fastest CAGR over the forecast period, driven by increasing demand for assisted reproductive services and greater willingness among patients to seek specialized fertility treatment internationally. Advances in reproductive technologies, improved communication infrastructure, and greater international mobility are making cross-border access to fertility services more feasible. In addition, countries such as India, Thailand, Turkey, and Singapore are attracting international patients through comparatively affordable treatment costs, specialized fertility centers, and supportive healthcare policies. The combination of treatment affordability, expanding clinical capabilities, and access to advanced reproductive technologies is expected to strengthen fertility services' position in the medical tourism landscape.

Service Provider Insights

The private segment accounted for the largest revenue share, at 54.8%, in 2025 and is projected to register the fastest growth over the forecast period. Rising healthcare costs in developed countries, combined with limited insurance coverage among certain patient groups, are encouraging individuals to seek comparatively affordable treatment options overseas. Private hospitals and healthcare networks in emerging destinations are increasingly targeting international patients by offering specialized procedures, shorter waiting times, and coordinated care services. Accreditation and quality certifications are also becoming important for building patient confidence, as healthcare providers strengthen international patient services to address concerns about treatment quality, communication, and safety.

To learn more about this report, Download Free Sample Report

The public segment is expected to witness substantial growth during the forecast period, supported by increasing cross-border patient mobility and greater integration of healthcare into national tourism strategies. The adoption of telemedicine, e-health platforms, and digital communication tools is improving access to pre-treatment consultations and enabling patients to coordinate care across countries. In addition, improvements in transportation infrastructure, hospitality services, and accommodation facilities are making international treatment more convenient. Government-backed healthcare initiatives and investments in medical infrastructure are further strengthening the ability of public healthcare systems to participate in the growing medical tourism ecosystem.

Country Insights

Turkey dominated the medical tourism market, accounting for 13.5% of global revenue in 2025. Istanbul, Antalya, and Ankara have emerged as key hubs, supported by established healthcare infrastructure, competitive treatment costs, and a strong tourism ecosystem. The country attracts international patients seeking aesthetic surgery, hair transplantation, dental care, bariatric procedures, and ophthalmology services, with treatment and associated travel expenses often considerably lower than in developed markets. For instance, heart valve replacement in the U.S. can cost approximately USD 80,000 to USD 120,000, compared with around USD 13,000 to USD 20,000 in Turkey. Cosmetic procedures represent a particularly important source of medical tourism revenue, accounting for approximately 32% of the country's medical tourism activity.

To learn more about this report, Download Free Sample Report

Mexico has emerged as a prominent medical tourism destination for patients from the U.S. and other North American markets, primarily due to its geographic proximity and comparatively lower treatment costs. The price differential is particularly attractive for procedures that may involve substantial out-of-pocket expenses in the U.S. Dental treatments can cost up to 70% less in Mexico, while cosmetic procedures can be up to 75% cheaper, creating a strong economic incentive for cross-border care. The availability of private hospitals, specialized clinics, and established medical tourism corridors near major border regions is further supporting Mexico's appeal among cost-conscious international patients.

India is strengthening its position as an international healthcare destination, supported by comparatively affordable treatment, a large pool of medical professionals, and expanding hospital infrastructure. The country offers a combination of modern medical services and traditional systems such as Ayurveda and other AYUSH-based therapies, creating a differentiated proposition for international patients. Government initiatives aimed at promoting health and wellness tourism, including infrastructure development for AYUSH services and greater international promotion, are further supporting the sector. In addition, the presence of healthcare facilities and medical services that meet internationally recognized standards is helping to strengthen patient confidence and India's competitiveness in the global market.

Key Medical Tourism Company Insights

Key players in the medical tourism market are increasingly focusing on geographic expansion, strategic partnerships, and service diversification to strengthen their international presence and attract a broader patient base. Healthcare providers are developing dedicated international patient services, collaborating with travel and hospitality companies, and establishing referral networks to streamline the patient journey from consultation through post-treatment care. Investments in digital platforms, virtual consultations, multilingual support, and coordinated travel arrangements are also becoming important differentiators. In addition, accreditation, specialized clinical expertise, and transparent pricing are helping providers build trust among international patients and strengthen their competitiveness across key medical tourism destinations.

Key Medical Tourism Companies

The following key companies have been profiled for this study of the medical tourism market.

• MOHW Hengchun Tourism Hospital

• Apollo Hospitals Enterprise Ltd.

• Bumrungrad International Hospital

• Mount Elizabeth Hospitals

• Raffles Medical Group

• Dr. B. L. Kapur Memorial Hospital

• Kasemrad Hospital International Rattanathibet

• Mission Hospital

• Bangkok Hospital

• Miot International

• Penang Adventist Hospital

Recent Developments

• In July 2026, the Royal Thai Government highlighted its efforts to position Thailand as a regional medical and wellness hub during the Thailand Medical & Wellness Expo 2026. The event brought together healthcare providers, investors, researchers, entrepreneurs, and other stakeholders, supporting Thailand's strategy to expand medical, wellness, and health-related services for international visitors.

• In June 2026, Dubai's General Directorate of Residency and Foreigners Affairs and Dubai Health Authority signed a strategic agreement to develop an integrated healthcare journey for international patients. The initiative aims to streamline medical visa and residency procedures and integrate healthcare-related services, supporting a more seamless experience for inbound medical tourists.

• In February 2026, the Government of India proposed establishing five Regional Medical Hubs through partnerships between state governments and the private sector to strengthen the country's medical tourism ecosystem. The integrated hubs are planned to combine healthcare, education, research, diagnostics, rehabilitation, AYUSH services, and facilitation of Medical Value Tourism, supporting India's positioning as a global medical tourism destination.

• In March 2025, Shanghai Renji Hospital and Singapore's Raffles Medical Group signed a strategic collaboration agreement to establish a “dual circulation” service system for medical resources. The partnership aims to introduce international service standards, cross-cultural care, and multilingual capabilities while supporting Shanghai's ambition to develop as a hub for international medical tourism.

Global Medical Tourism Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2035. For this study, Grand View Research has segmented the medical tourism market report based on treatment type, service provider, and country:

To learn more about this report, Download Free Sample Report

• Treatment Type Outlook (Revenue, USD Million, 2021 - 2035)

  • Cardiovascular treatment

  • Orthopedic treatment

  • Cosmetic treatment

  • Bariatric treatment

  • Dental treatment

  • Ophthalmology treatment

  • Infertility treatment

  • Alternative medicine

  • Other services

• Service Provider Outlook (Revenue, USD Million, 2021 - 2035)

  • Public

  • Private

• Country Outlook (Revenue, USD Million, 2021 - 2035)

  • U.S.

  • China

  • Australia

  • Indonesia

  • Malaysia

  • Thailand

  • Singapore

  • South Korea

  • India

  • Taiwan

  • Spain

  • Czech Republic

  • Brazil

  • Mexico

  • Colombia

  • Costa Rica

  • Turkey

  • Philippines